Glen Gejerman, MD
Radiation Oncology · Hackensack, NJNPI 1972565182
Payments from drug & device makers
Across 153 payments — averaging $4125.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Palette Life Sciences, Inc.$291K
- Teleflex LLC$168K
- Boston Scientific$147K
- Novartis$14K
- Bayer$10K
- Teleflex Incorporated$119
- plus $211 from 6 others
What the payments were for
- Consulting fees$100,64956%
- Speaking & faculty fees$71,79940%
- Travel & lodging$6,3734%
- Food & beverage$1,4631%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Palette Life Sciences, Inc. | 17 | $291,317 |
| Teleflex LLC | 51 | $168,478 |
| Boston Scientific | 49 | $146,885 |
| Novartis | 11 | $13,677 |
| Bayer | 15 | $10,485 |
| Teleflex Incorporated | 1 | $119 |
| Johnson & Johnson | 4 | $64 |
| Elekta, Inc. | 1 | $48 |
| Varian Medical Systems, Inc. | 1 | $30 |
| AstraZeneca | 1 | $30 |
| Blue Earth Diagnostics | 1 | $29 |
| Myriad Genetic Laboratories, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barrigel$34,903
- SpaceOAR VUE System - 10mL$15,770
- PLUVICTO$13,127
- Xofigo$8,345
- SPACEOAR VUE$6,571
- Non-Covered$2,016
- SPACEOAR$900
- UroLift$119
How this compares
$631,171 in reported general payments places this provider in the 95th percentile of 132 radiation oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 324 | $4,953 |
| Alendronate Sodium | 62 | $657 |
| Ciprofloxacin Hcl | 309 | $530 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $8 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Hackensack
- Brett LewisHackensack$122K
- Nicholas DenunzioHackensack$4K
- Atif KhanNew Brunswick$4.7M
- Salma JabbourNew Brunswick$2.9M
- Michael GreenbergCherry Hill$335K
- Yao YuMiddletown$303K
- Marc RudoltzWest Orange$166K
- Edward SoffenMonroe Twp$165K
- Bruce HafftyNew Brunswick$81K
- Adnan DanishWayne$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.